Shionogi
Mercy James, PhD, RAC has a strong background in regulatory affairs, with notable experience at Shionogi Inc., Bausch Health Companies Inc. Mercy recently joined Bausch Health Companies Inc. as the Director of Global Regulatory Affairs in April 2021. Prior to that, Mercy held the position of Associate Director at Bausch Health Companies Inc. from September 2017 to August 2020. It is unclear when they started their role as Director of Regulatory Affairs at Shionogi Inc. due to missing start year information.
Mercy James, PhD, RAC has obtained a Doctor of Philosophy (PhD) degree from Iowa State University. In addition to their PhD, they have also received certifications in Regulatory Affairs from the Regulatory Affairs Certification Program. Mercy obtained the first certification in September 2010 and the second certification at an unspecified date in 2013.
This person is not in the org chart
This person is not in any offices
Shionogi
10 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.